656 related articles for article (PubMed ID: 30685336)
1. GDF15 acts synergistically with liraglutide but is not necessary for the weight loss induced by bariatric surgery in mice.
Frikke-Schmidt H; Hultman K; Galaske JW; Jørgensen SB; Myers MG; Seeley RJ
Mol Metab; 2019 Mar; 21():13-21. PubMed ID: 30685336
[TBL] [Abstract][Full Text] [Related]
2. GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates.
Mullican SE; Lin-Schmidt X; Chin CN; Chavez JA; Furman JL; Armstrong AA; Beck SC; South VJ; Dinh TQ; Cash-Mason TD; Cavanaugh CR; Nelson S; Huang C; Hunter MJ; Rangwala SM
Nat Med; 2017 Oct; 23(10):1150-1157. PubMed ID: 28846097
[TBL] [Abstract][Full Text] [Related]
3. GDF15 mediates adiposity resistance through actions on GFRAL neurons in the hindbrain AP/NTS.
Tsai VW; Zhang HP; Manandhar R; Schofield P; Christ D; Lee-Ng KKM; Lebhar H; Marquis CP; Husaini Y; Brown DA; Breit SN
Int J Obes (Lond); 2019 Dec; 43(12):2370-2380. PubMed ID: 31152154
[TBL] [Abstract][Full Text] [Related]
4. Camptothecin effectively treats obesity in mice through GDF15 induction.
Lu JF; Zhu MQ; Xie BC; Shi XC; Liu H; Zhang RX; Xia B; Wu JW
PLoS Biol; 2022 Feb; 20(2):e3001517. PubMed ID: 35202387
[TBL] [Abstract][Full Text] [Related]
5. The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL.
Emmerson PJ; Wang F; Du Y; Liu Q; Pickard RT; Gonciarz MD; Coskun T; Hamang MJ; Sindelar DK; Ballman KK; Foltz LA; Muppidi A; Alsina-Fernandez J; Barnard GC; Tang JX; Liu X; Mao X; Siegel R; Sloan JH; Mitchell PJ; Zhang BB; Gimeno RE; Shan B; Wu X
Nat Med; 2017 Oct; 23(10):1215-1219. PubMed ID: 28846098
[TBL] [Abstract][Full Text] [Related]
6. GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand.
Yang L; Chang CC; Sun Z; Madsen D; Zhu H; Padkjær SB; Wu X; Huang T; Hultman K; Paulsen SJ; Wang J; Bugge A; Frantzen JB; Nørgaard P; Jeppesen JF; Yang Z; Secher A; Chen H; Li X; John LM; Shan B; He Z; Gao X; Su J; Hansen KT; Yang W; Jørgensen SB
Nat Med; 2017 Oct; 23(10):1158-1166. PubMed ID: 28846099
[TBL] [Abstract][Full Text] [Related]
7. Running on mixed fuel-dual agonistic approach of GLP-1 and GCG receptors leads to beneficial impact on body weight and blood glucose control: A comparative study between mice and non-human primates.
Elvert R; Herling AW; Bossart M; Weiss T; Zhang B; Wenski P; Wandschneider J; Kleutsch S; Butty U; Kannt A; Wagner M; Haack T; Evers A; Dudda A; Lorenz M; Keil S; Larsen PJ
Diabetes Obes Metab; 2018 Aug; 20(8):1836-1851. PubMed ID: 29938884
[TBL] [Abstract][Full Text] [Related]
8. Liraglutide Modulates Appetite and Body Weight Through Glucagon-Like Peptide 1 Receptor-Expressing Glutamatergic Neurons.
Adams JM; Pei H; Sandoval DA; Seeley RJ; Chang RB; Liberles SD; Olson DP
Diabetes; 2018 Aug; 67(8):1538-1548. PubMed ID: 29776968
[TBL] [Abstract][Full Text] [Related]
9. Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15.
Hsu JY; Crawley S; Chen M; Ayupova DA; Lindhout DA; Higbee J; Kutach A; Joo W; Gao Z; Fu D; To C; Mondal K; Li B; Kekatpure A; Wang M; Laird T; Horner G; Chan J; McEntee M; Lopez M; Lakshminarasimhan D; White A; Wang SP; Yao J; Yie J; Matern H; Solloway M; Haldankar R; Parsons T; Tang J; Shen WD; Alice Chen Y; Tian H; Allan BB
Nature; 2017 Oct; 550(7675):255-259. PubMed ID: 28953886
[TBL] [Abstract][Full Text] [Related]
10. GDF15 enhances body weight and adiposity reduction in obese mice by leveraging the leptin pathway.
Breit SN; Manandhar R; Zhang HP; Lee-Ng M; Brown DA; Tsai VW
Cell Metab; 2023 Aug; 35(8):1341-1355.e3. PubMed ID: 37433299
[TBL] [Abstract][Full Text] [Related]
11. Single nuclei RNA sequencing of the rat AP and NTS following GDF15 treatment.
Reiner BC; Crist RC; Borner T; Doyle RP; Hayes MR; De Jonghe BC
Mol Metab; 2022 Feb; 56():101422. PubMed ID: 34942400
[TBL] [Abstract][Full Text] [Related]
12. The GDF15-GFRAL pathway is dispensable for the effects of metformin on energy balance.
Klein AB; Nicolaisen TS; Johann K; Fritzen AM; Mathiesen CV; Gil C; Pilmark NS; Karstoft K; Blond MB; Quist JS; Seeley RJ; Færch K; Lund J; Kleinert M; Clemmensen C
Cell Rep; 2022 Aug; 40(8):111258. PubMed ID: 36001956
[TBL] [Abstract][Full Text] [Related]
13. GDF15 mediates the effects of metformin on body weight and energy balance.
Coll AP; Chen M; Taskar P; Rimmington D; Patel S; Tadross JA; Cimino I; Yang M; Welsh P; Virtue S; Goldspink DA; Miedzybrodzka EL; Konopka AR; Esponda RR; Huang JT; Tung YCL; Rodriguez-Cuenca S; Tomaz RA; Harding HP; Melvin A; Yeo GSH; Preiss D; Vidal-Puig A; Vallier L; Nair KS; Wareham NJ; Ron D; Gribble FM; Reimann F; Sattar N; Savage DB; Allan BB; O'Rahilly S
Nature; 2020 Feb; 578(7795):444-448. PubMed ID: 31875646
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Glucose Control Following Vertical Sleeve Gastrectomy Does Not Require a β-Cell Glucagon-Like Peptide 1 Receptor.
Douros JD; Lewis AG; Smith EP; Niu J; Capozzi M; Wittmann A; Campbell J; Tong J; Wagner C; Mahbod P; Seeley R; D'Alessio DA
Diabetes; 2018 Aug; 67(8):1504-1511. PubMed ID: 29759973
[TBL] [Abstract][Full Text] [Related]
15. Obesity medication lorcaserin activates brainstem GLP-1 neurons to reduce food intake and augments GLP-1 receptor agonist induced appetite suppression.
Wagner S; Brierley DI; Leeson-Payne A; Jiang W; Chianese R; Lam BYH; Dowsett GKC; Cristiano C; Lyons D; Reimann F; Gribble FM; Martinez de Morentin PB; Yeo GSH; Trapp S; Heisler LK
Mol Metab; 2023 Feb; 68():101665. PubMed ID: 36592795
[TBL] [Abstract][Full Text] [Related]
16. GABA neurons in the nucleus tractus solitarius express GLP-1 receptors and mediate anorectic effects of liraglutide in rats.
Fortin SM; Lipsky RK; Lhamo R; Chen J; Kim E; Borner T; Schmidt HD; Hayes MR
Sci Transl Med; 2020 Mar; 12(533):. PubMed ID: 32132220
[TBL] [Abstract][Full Text] [Related]
17. Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism.
Mroz PA; Finan B; Gelfanov V; Yang B; Tschöp MH; DiMarchi RD; Perez-Tilve D
Mol Metab; 2019 Feb; 20():51-62. PubMed ID: 30578168
[TBL] [Abstract][Full Text] [Related]
18. Metformin triggers a kidney GDF15-dependent area postrema axis to regulate food intake and body weight.
Zhang SY; Bruce K; Danaei Z; Li RJW; Barros DR; Kuah R; Lim YM; Mariani LH; Cherney DZ; Chiu JFM; Reich HN; Lam TKT
Cell Metab; 2023 May; 35(5):875-886.e5. PubMed ID: 37060902
[TBL] [Abstract][Full Text] [Related]
19. Growth differentiation factor 15 as a potential therapeutic for treating obesity.
Hale C; Véniant MM
Mol Metab; 2021 Apr; 46():101117. PubMed ID: 33220493
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor-21 is required for weight loss induced by the glucagon-like peptide-1 receptor agonist liraglutide in male mice fed high carbohydrate diets.
Le TDV; Fathi P; Watters AB; Ellis BJ; Besing GK; Bozadjieva-Kramer N; Perez MB; Sullivan AI; Rose JP; Baggio LL; Koehler J; Brown JL; Bales MB; Nwaba KG; Campbell JE; Drucker DJ; Potthoff MJ; Seeley RJ; Ayala JE
Mol Metab; 2023 Jun; 72():101718. PubMed ID: 37030441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
